KAYLA SANDERS: Open Payments
NPI 1104589035 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 5 payments from 3 companies in 2025. Trend: 2023 $488 · 2024 $435 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 1 | $118 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
Products named: LYBALVI, INGREZZA, UZEDY.
Industry payments across LA — which companies pay providers there.
